These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 30267494)

  • 1. The relationship between obesity, glycemia and leptin level of type 2 diabetes mellitus patients with metabolic syndrome.
    Marusyn OV
    Wiad Lek; 2018; 71(6):1165-1168. PubMed ID: 30267494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
    Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease.
    Nar A; Gedik O
    Acta Diabetol; 2009 Jun; 46(2):113-8. PubMed ID: 18839053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of glimepiride and insulin sensitizers in the treatment of type 2 diabetes--a study in Indians.
    Ramachandran A; Snehalatha C; Salini J; Vijay V
    J Assoc Physicians India; 2004 Jun; 52():459-63. PubMed ID: 15645955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels.
    Komori T; Yoshida F; Nakamura J; Miyazaki S; Miura H; Iguchi A
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):422-8. PubMed ID: 15372361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.
    Bermúdez V; Cano R; Cano C; Bermúdez F; Leal E; Acosta K; Mengual E; Arraiz N; Briceño C; Gómez J; Bustamante M; Aparicio D; Cabrera M; Valdelamar L; Rodriguez M; Manuel V; Hernández R
    Am J Ther; 2008; 15(4):409-16. PubMed ID: 18645347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of rosiglitazone on serum leptin and insulin resistance in patients with Type 2 diabetes].
    Wu J; Lei MX; Chen HL; Sun ZX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):623-6. PubMed ID: 16114542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs.
    Farooq R; Amin S; Hayat Bhat M; Malik R; Wani HA; Majid S
    Gynecol Endocrinol; 2017 Jan; 33(1):75-78. PubMed ID: 27705028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
    Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE IMPACT OF THE DEGREE OF OBESITY ON METABOLIC PARAMETERS IN CHILDREN AND ADOLESCENTS.
    Tskhvedadze N; Giorgadze E; Janjgava S
    Georgian Med News; 2018 Dec; (285):51-56. PubMed ID: 30702070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
    Derosa G; Salvadeo SA; D'Angelo A; Fogari E; Ragonesi PD; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Arch Med Res; 2008 May; 39(4):412-9. PubMed ID: 18375253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.
    Zimmet P; Collier G
    Drugs; 1999; 58 Suppl 1():21-8; discussion 75-82. PubMed ID: 10576521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients.
    Firouzjaei A; Li GC; Wang N; Liu WX; Zhu BM
    Nutr Diabetes; 2016 May; 6(5):e209. PubMed ID: 27136447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.
    Fanghänel G; Sánchez-Reyes L; Trujillo C; Sotres D; Espinosa-Campos J
    Diabetes Care; 1996 Nov; 19(11):1185-9. PubMed ID: 8908377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial.
    Esteghamati A; Noshad S; Rabizadeh S; Ghavami M; Zandieh A; Nakhjavani M
    Regul Pept; 2013 Mar; 182():1-6. PubMed ID: 23328000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
    Inoue M; Maehata E; Yano M; Taniyama M; Suzuki S
    Metabolism; 2005 Mar; 54(3):281-6. PubMed ID: 15736103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.